We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Coinbase
COIN
$43.4B
| $1.93M | ﹤0.01% |
26,914
-47,228
| -64% | -$2.82M |
|
|
TBI
952
Trueblue
TBI
$276M
| $1.92M | ﹤0.01% |
108,460
+5,921
| +6% | +$100K |
|
|
PRA
953
DELISTED
ProAssurance
PRA
| $1.92M | ﹤0.01% |
127,008
-369,976
| -74% | -$5.82M |
|
954
ALX Oncology
ALXO
$243M
| $1.91M | ﹤0.01% |
254,970
-255,696
| -50% | -$1.67M |
|
955
Dropbox
DBX
$8.21B
| $1.91M | ﹤0.01% |
71,471
+48,919
| +217% | +$1.12M |
|
|
TRHC
956
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $1.91M | ﹤0.01% |
230,968
-12,457
| -5% | -$74.5K |
|
957
Colgate-Palmolive
CL
$69.4B
| $1.91M | ﹤0.01% |
24,733
+20,448
| +477% | +$1.58M |
|
958
Manhattan Associates
MANH
$12.4B
| $1.91M | ﹤0.01% |
9,532
+517
| +6% | +$89.8K |
|
959
PennyMac Financial
PFSI
$3.43B
| $1.9M | ﹤0.01% |
+27,061
| New | +$1.71M |
|
960
Halozyme
HALO
$12.3B
| $1.9M | ﹤0.01% |
52,683
+9,416
| +22% | +$321K |
|
|
ICPT
961
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.9M | ﹤0.01% |
171,750
+69,004
| +67% | +$961K |
|
962
Honeywell
HON
$65.8B
| $1.9M | ﹤0.01% |
9,691
-62,739
| -87% | -$11.7M |
|
963
Regeneron Pharmaceuticals
REGN
$79.7B
| $1.89M | ﹤0.01% |
2,636
+335
| +15% | +$258K |
|
964
Markel Group
MKL
$22.1B
| $1.89M | ﹤0.01% |
1,369
-100
| -7% | -$134K |
|
965
LGI Homes
LGIH
$1.14B
| $1.89M | ﹤0.01% |
14,010
-5,488
| -28% | -$658K |
|
966
Telos
TLS
$305M
| $1.89M | ﹤0.01% |
737,404
-1,219,512
| -62% | -$2.89M |
|
967
Enerpac Tool Group
EPAC
$1.83B
| $1.89M | ﹤0.01% |
69,886
| – | – |
|
968
First Business Financial Services
FBIZ
$600M
| $1.88M | ﹤0.01% |
63,831
-1,087
| -2% | -$30.8K |
|
|
AZEK
969
DELISTED
The AZEK Co
AZEK
| $1.88M | ﹤0.01% |
62,027
+14,860
| +32% | +$384K |
|
970
Rimini Street
RMNI
$417M
| $1.85M | ﹤0.01% |
386,741
-7,510
| -2% | -$31.1K |
|
971
Virtu Financial
VIRT
$5.06B
| $1.85M | ﹤0.01% |
108,258
+189
| +0.2% | +$3.47K |
|
972
Emergent Biosolutions
EBS
$346M
| $1.85M | ﹤0.01% |
251,501
-444,230
| -64% | -$4.12M |
|
|
LSI
973
DELISTED
Life Storage, Inc.
LSI
| $1.85M | ﹤0.01% |
13,898
+1,506
| +12% | +$200K |
|
974
New Jersey Resources
NJR
$5.43B
| $1.83M | ﹤0.01% |
38,867
-497
| -1% | -$25K |
|
975
Flywire
FLYW
$2.17B
| $1.83M | ﹤0.01% |
+59,021
| New | +$1.77M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.